EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Aspirin in Primary Prevention: Looking for Those Who Enjoy It

Roberta Della Bona iD, Simona Giubilato iD, Marco Palmieri iD, Stefano Benenati iD, Roberta Rossini, Stefania Angela Di Fusco iD, Filippo Novarese, Giuseppe Mascia iD, Nicola Gasparetto, Antonio Di Monaco iD, Laura Gatto, Filippo Zilio und 10 weitere

Journal of Clinical Medicine · 16.07.2024 · 13 (14) · 4148

DOI: 10.3390/jcm13144148 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 16.07.2024. Verfasst von Roberta Della Bona und 21 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Based on a wealth of evidence, aspirin is one of the cornerstones of secondary prevention of cardiovascular disease. However, despite several studies showing efficacy also in primary prevention, an unopposed excess risk of bleeding leading to a very thin safety margin is evident in subjects without a clear acute cardiovascular event. Overall, the variability in recommendations from different scientific societies for aspirin use in primary prevention is a classic example of failure of simple risk stratification models based on competing risks (atherothrombosis vs. bleeding), perceived to be opposed but intertwined at the pathophysiological level. Notably, cardiovascular risk is dynamic in nature and cannot be accurately captured by scores, which do not always consider risk enhancers. Furthermore, the widespread use of other potent medications in primary prevention, such as lipid-lowering and anti-hypertensive drugs, might be reducing the benefit of aspirin in recent trials. Some authors, drawing from specific pathophysiological data, have suggested that specific subgroups might benefit more from aspirin. This includes patients with diabetes and those with obesity; sex-based differences are considered as well. Moreover, molecular analysis of platelet reactivity has been proposed. A beneficial effect of aspirin has also been demonstrated for the prevention of cancer, especially colorectal. This review explores evidence and controversies concerning the use of aspirin in primary prevention, considering new perspectives in order to provide a comprehensive individualized approach.

Schlagwörter

Stichwörter der Autor:innen

aspirinbleedingcancercardiovascular riskdiabetesguidelinesplateletprimary preventionthrombosis

Autor:innen und Institutionen

  • Cardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy.
  • Cardiology Department, Cannizzaro Hospital, 95126 Catania, Italy.
  • Department of Internal Medicine (Di.M.I.), University of Genova, 16132 Genoa, Italy.
  • Division of Cardiology, Emergency Department and Critical Areas, Azienda Ospedaliera Santa Croce e Carle, 12100 Cuneo, Italy.
  • Cardiology Department, San Filippo Neri Hospital, ASL Roma 1, 00135 Rome, Italy.
  • Division of Cardiology, AULSS2 Marca Trevigiana, Ca' Foncello Hospital, 31100 Treviso, Italy.

ORCID-Profile: Roberta Della Bona, Simona Giubilato, Marco Palmieri, Stefano Benenati, Stefania Angela Di Fusco, Giuseppe Mascia, Antonio Di Monaco, Giovanna Geraci, Furio Colivicchi, Massimo Grimaldi, Italo Porto

Zitieren

APA

Della Bona, R., Giubilato, S., Palmieri, M., Benenati, S., Rossini, R., Di Fusco, S. A., Novarese, F., Mascia, G., Gasparetto, N., Di Monaco, A., Gatto, L., Zilio, F., Sorini Dini, C., Borrello, F., Geraci, G., Riccio, C., De Luca, L., Colivicchi, F., Grimaldi, M., …, & Oliva, F. G. (2024). Aspirin in Primary Prevention: Looking for Those Who Enjoy It. Journal of Clinical Medicine, 13(14), 4148. https://doi.org/10.3390/jcm13144148

Vancouver

Della Bona R, Giubilato S, Palmieri M, Benenati S, Rossini R, Di Fusco SA, et al. Aspirin in Primary Prevention: Looking for Those Who Enjoy It. Journal of Clinical Medicine. 2024;13(14):4148. doi:10.3390/jcm13144148

BibTeX
@article{DellaBona2024,
  author = {Della Bona, Roberta and Giubilato, Simona and Palmieri, Marco and Benenati, Stefano and Rossini, Roberta and Di Fusco, Stefania Angela and Novarese, Filippo and Mascia, Giuseppe and Gasparetto, Nicola and Di Monaco, Antonio and Gatto, Laura and Zilio, Filippo and Sorini Dini, Carlotta and Borrello, Francesco and Geraci, Giovanna and Riccio, Carmine and De Luca, Leonardo and Colivicchi, Furio and Grimaldi, Massimo and Giulizia, Michele Massimo and Porto, Italo and Oliva, Fabrizio Giovanni},
  title = {Aspirin in Primary Prevention: Looking for Those Who Enjoy It},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {14},
  pages = {4148},
  doi = {10.3390/jcm13144148}
}
Kostenlos starten →